Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


An, US

Bo An, Amherst, MA US

Patent application numberDescriptionPublished
20090282415Method and Apparatus for Negotiation Management in Data Processing Systems - Techniques are disclosed for optimizing schedules used in implementing plans for performing tasks in data processing systems. For example, an automated method of negotiating for resources in a data processing system, wherein the data processing system comprises multiple sites, comprises a negotiation management component of a computer system at a given one of the sites performing the following steps. One or more tasks from at least one source of one or more plans are obtained. Each plan is annotated with one or more needed resources and one or more potential resource providers at one or more sites in the data processing system. An optimized resource negotiation schedule based on the one or more obtained tasks is computed. The schedule comprises an order in which resources are negotiated. In accordance with the optimized resource negotiation schedule, a request for each needed resource is sent to the one or more potential resource providers such that a negotiation process is performed between the negotiation management component and at least one of the potential resource providers.11-12-2009

Bob (robert) An, Bridgewater, NJ US

Patent application numberDescriptionPublished
20080249020Human Growth Hormone Treatment Methods - New methods for developing dosing formulas that allow the determination of appropriate dosage regimens for human growth hormone (hGH) compounds; methods for using such formulas to calculate individualized hGH compound dosage regimens; methods for treatment of hGH-responsive syndromes in patients using such determined regimens; systems, devices, and computer-readable media comprising instructions for receiving predictive value information and for generating dosage regimens and/or dosing formulas; and other related systems and methods are provided by the invention described herein.10-09-2008

Chae H. An, Northville, MI US

Patent application numberDescriptionPublished
20090174221Locating Structure For An Instrument Panel Assembly Of A Motor Vehicle - An instrument panel assembly for a motor vehicle includes a first component, a second component and a frame. The first component has a first aperture. The second component has a second aperture. The frame has a main wall. The frame includes a generally cylindrical boss extending outwardly from the main wall. The boss has an outer surface. The boss has a bore aligned with the first aperture of the first component to receive a fastener therethrough to secure the first component to the frame. The boss extends through the second aperture of the second component such that the outer surface locates the second component relative to the frame along a plane generally orthogonal to a longitudinal axis of the boss. The second component is disposed between the first component and the frame so as to be constrained along the longitudinal axis of the boss.07-09-2009

Chae Hon An, Northville, MI US

Patent application numberDescriptionPublished
20090156113Motor Vehicle Instrument Panel Assembly Having A Conduit With A Gasket Support Lip - An instrument panel assembly for a motor vehicle includes a panel member, a first conduit, a second conduit and a gasket disposed between the first and second conduit. The panel member has a vent for directing air toward a window in the vehicle. The first conduit has a first end coupled to a bottom side of the panel member and providing air to the vent. The first conduit has a second end with a peripheral wall forming an inlet. The second conduit has an outlet that provides air to the inlet of the first conduit. The second conduit has a flange that extends outwardly from the outlet and includes a support surface that supports a gasket for sealing an interface between the outlet of the second conduit and the inlet of tie first conduit. The second conduit has a lip that extends outwardly from the support surface of the flange and supports the gasket to prevent deformation of the gasket during assembly of the first conduit and second conduit.06-18-2009

Chong Pyung An, Painted Post, NY US

Patent application numberDescriptionPublished
20080200088Method for reducing interference fringes in a display device - A method of minimizing the formation of interference fringes in an OLED display device is disclosed comprising sealing the upper and lower glass substrates comprising the display device to one another within an enclosure wherein a pressure of the atmosphere within the enclosure is greater than the pressure of the atmosphere outside the enclosure.08-21-2008
20090324830TIN PHOSPHATE BARRIER FILM, METHOD, AND APPARATUS - A method is disclosed for inhibiting oxygen and moisture penetration of a device comprising the steps of depositing a tin phosphate low liquidus temperature (LLT) inorganic material on at least a portion of the device to create a deposited tin phosphate LLT material, and heat treating the deposited LLT material in a substantially oxygen and moisture free environment to form a hermetic seal; wherein the step of depositing the LLT material comprises the use of a resistive heating element comprising tungsten. An organic electronic device is also disclosed comprising a substrate plate, at least one electronic or optoelectronic layer, and a tin phosphate LLT barrier layer, wherein the electronic or optoelectronic layer is hermetically sealed between the tin phosphate LLT barrier layer and the substrate plate. An apparatus is also disclosed having at least a portion thereof sealed with a tin phosphate LLT barrier layer.12-31-2009
20100051817Systems and methods for determining the shape of glass sheets - Disclosed are systems and methods for determining the shape of a glass sheet during and/or after the forming process. In one example, a system for determining the shape of a glass sheet defining an interior bulk can include a light source, an image capture device and a processor that are configured to calculate the location of an energy centroid within a selected portion of the bulk of the glass sheet.03-04-2010
20100193353SEALING TECHNIQUE FOR DECREASING THE TIME IT TAKES TO HERMETICALLY SEAL A DEVICE AND THE RESULTING HERMETICALLY SEALED DEVICE - A sealing method for decreasing the time it takes to hermetically seal a device and the resulting hermetically sealed device (e.g., a hermetically sealed OLED device) are described herein. The sealing method includes the steps of: (1) cooling an un-encapsulated device; (2) depositing a sealing material over at least a portion of the cooled device to form an encapsulated device; and (3) heat treating the encapsulated device to form a hermetically sealed device. In one embodiment, the sealing material is a low liquidus temperature inorganic (LLT) material such as, for example, tin-fluorophosphate glass, tungsten-doped tin fluorophosphate glass, chalcogenide glass, tellurite glass, borate glass and phosphate glass. In another embodiment, the sealing material is a Sn08-05-2010
20120028011SELF-PASSIVATING MECHANICALLY STABLE HERMETIC THIN FILM - A hermetic thin film includes a first inorganic layer and a second inorganic layer contiguous with the first inorganic layer, wherein the second inorganic layer is formed as a reaction product of the first inorganic layer with oxygen and has a molar volume that is about −1% to 15% greater than a molar volume of the first inorganic layer. An equilibrium thickness of the second inorganic layer is at least 10% of but less than an as-deposited thickness of the first inorganic layer.02-02-2012

Patent applications by Chong Pyung An, Painted Post, NY US

Fenqgi An, Solon, OH US

Patent application numberDescriptionPublished
20110182910METHOD OF TREATING T CELL MEDIATED DISORDERS - A method of treating a T-cell mediated disorders in a tissue includes administering to the tissue of the subject a therapeutically effective amount of a complement antagonist that substantially reduces T-cell differentiation or t-cell inflammatory cytokine generation.07-28-2011

Gang An, Oklahoma City, OK US

Patent application numberDescriptionPublished
20110286917Novel, Prostate-Specific Gene for Diagnosis, Prognosis and Management of Prostate Cancer - Disclosed are nucleic acid and amino acid sequences encoded by a novel, prostate specific gene (UC41) and diagnostic techniques for the detection of human prostate cancer utilizing such nucleic acid and amino acid sequences. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate cancer are described. Methods of treatment for prostate cancer utilizing antisense constructs or antibodies specific for UC41 gene products are also described.11-24-2011

Gary An, Chicago, IL US

Patent application numberDescriptionPublished
20080228456MODELING WOUND HEALING - Provided are methods of simulating tissue healing. The methods comprise using a mechanistic computer model of the interrelated effects of inflammation, tissue damage or dysfunction and tissue healing to predict an outcome of healing of damaged tissue in vivo, thereby predicting the outcome of healing of damaged tissue in vivo. Implementations of these methods on a computing device also are provided. Non-limiting examples of diseases and/or conditions that are amenable to simulation according to the methods described herein include: a diabetes, diabetic foot ulcers, necrotizing enterocolitis, ulcerative colitis, Crohn's disease, inflammatory bowel disease, restenosis (post-angioplasty or stent implantation), incisional wounding, excisional wounding, surgery, accidental trauma, pressure ulcer, stasis ulcer, tendon rupture, vocal fold phonotrauma, otitis media and pancreatitis.09-18-2008

Hailing An, Houston, TX US

Patent application numberDescriptionPublished
20100161250SUBSEA CONTROL SYSTEM DIAGNOSIS - Accurate, dependable methods for analyzing operational parameters of subsea control systems and diagnosis/prediction of failures are provided, in particular, methods for detection of leaking and/or clogging in hydraulic control system using recorded pressure signals and evaluating response communication strength (signal amplitude) of field equipment from, for example, subsea control systems. Prediction of failure(s) allows an opportunity to prepare for intervention to minimize the impact of failure before failure occurs, for example, by ordering equipment, tools and/or scheduling an intervention vessel. Similarly, diagnosing a failure drastically shortens the intervention time.06-24-2010
20110114329APPARATUS AND METHOD FOR PROVIDING A CONTROLLABLE SUPPLY OF FLUID TO SUBSEA WELL EQUIPMENT - An apparatus and method for providing a controllable supply of fluid, and optionally power and/or communication signals, to a subsea equipment are provided. The fluid may be a water-based fluid, oil-based fluid, or chemicals. The apparatus includes a reservoir disposed on a seabed for storing a supply of fluid for delivery to the subsea well equipment. A subsea pumping device is configured to receive the fluid from the reservoir, pressurize the fluid, and deliver the pressurized fluid to an accumulator of a hydraulic power unit disposed on the seabed. The hydraulic power unit can store the pressurized fluid and control an output of the pressurized fluid to the subsea well equipment, thereby providing a subsea fluid source for the subsea equipment.05-19-2011

Hongmei An, Houston, TX US

Patent application numberDescriptionPublished
20090031712CATALYSTS WITH SLOW, PASSIVE RELEASE OF ALKALI IONS - Described is a method of slowly releasing a catalyst for, inter alia, the purpose of soot oxidation in a particulate filter. An example method includes incorporating an alkali metal oxide in a glass. Slow leaching of the alkali from the glass provides a means to gradually deliver the catalyst over extended periods. Additionally, the example method includes increasing the amount of alkaline metal ions that may be leached from the glass.02-05-2009

Howard S. An, Riverwood, IL US

Patent application numberDescriptionPublished
20090142311ENGINEERED INTERVERTEBRAL DISC TISSUE - Surgically implantable tissue engineered intervertebral disc tissues that effectively replicate the physicochemical properties of the corresponding in vivo tissues are provided. Methods for producing such tissues can involve culturing the intervertebral disc cells to produce cells surrounded by an extracellular matrix and culturing the cells and matrix on a semipermeable membrane to form a cohesive tissue.06-04-2009

Howard S. An, Glenview, IL US

Patent application numberDescriptionPublished
20110106168Laminoplasty Rod System - A laminoplasty rod and rod system that allows for variable angulation, translation (distraction and/or compression) and rotation of a spinal lamina bone portion associated with a laminoplasty, prior to fixation thereof. The laminoplasty rod is configured for use with a polyaxial spinal rod bone screw assembly that is adapted to be anchored to the vertebra associated with the laminoplasty, and is attachable to the spinal lamina bone portion. The laminoplasty rod system provides positional attachment of the laminoplasty rod to the spinal components associated with the laminoplasty and fixation thereof in various orientations. The laminoplasty rod system is characterized by a configured laminoplasty rod that fits into or onto the head of a polyaxial spinal rod bone screw assembly. A bone screw boss, defining a bone screw attachment configuration, is formed at one end of the laminoplasty rod. Preferably, but not necessarily, the bone screw boss is situated at an angled end of the rod having a pre-defined bend that provides for greater variation in rod orientation.05-05-2011

Hui Chul An US

Patent application numberDescriptionPublished
20120120657FRONT LIGHT UNIT - Disclosed herein is a front light unit including a transparent insulating substrate; a transparent anode electrode disposed on the insulating substrate; a plurality of organic light-emitting elements disposed on the anode electrode; a transparent cathode electrode disposed on the organic light-emitting elements; and a plurality of reflective plates disposed opposite the organic light-emitting elements in an emission direction of the organic light-emitting elements, and disposed between the insulating substrate and the cathode electrode.05-17-2012

Jiandi An, Austin, TX US

Patent application numberDescriptionPublished
20110271008Selective TCP Large Receive Aggregation Based On IP Destination Address - An information handling device receives a packet and determines a packet destination for the packet. In turn, the information handling device either aggregates the packet in response to determining that the packet destination is a local destination, or forwards the packet in response to determining that the packet destination is a non-local destination.11-03-2011

Jihyun An, Evanston, IL US

Patent application numberDescriptionPublished
20110104213Porous Biomolecule-Containing Metal-Organic Frameworks - The present invention relates to compositions including porous biomolecule-containing metal-organic frameworks and methods for their preparation. The porous biomolecule-containing metal-organic frameworks can include a metal component and a biomolecule component. The pores located within the frameworks have a pore space and said pore space is capable to adsorb materials therein. These compositions of the present invention are useful in a wide variety of applications, such as, but not limited to, hydrogen and carbon dioxide sequestration, separation and storage; carbon dioxide uptake; and drug storage and release.05-05-2011

Ju Jin An, Cambridge, MA US

Patent application numberDescriptionPublished
20090047447Method for removing surface deposits and passivating interior surfaces of the interior of a chemical vapor deposition reactor - The present invention relates to plasma cleaning methods for removing surface deposits from a surface, such as the interior of a depositions chamber that is used in fabricating electronic devices. The present invention also provides gas mixtures and activated gas mixtures which provide superior performance in removing deposits from a surface. The methods involve activating a gas mixture comprising a carbon or sulfur source, NF02-19-2009

Patent applications by Ju Jin An, Cambridge, MA US

Kai-Nam An, Rocheser, MN US

Patent application numberDescriptionPublished
20110237949SYSTEM AND METHOD FOR ANALYZING CARPAL TUNNEL USING ULTRASOUND IMAGING - A system and method is provided for using dynamic ultrasonic imaging to analyze a subject's carpal tunnel and generate risk factors indicative of the health of the subject's subsynovial connective tissue and the subject's risk of developing carpal tunnel syndrome. The system and method uses speckle imaging techniques to track dynamic structures within the carpal tunnel and statistical analysis techniques to compare the properties of these dynamic structures of the subject to those of normal subjects and subjects having carpal tunnel syndrome.09-29-2011

Kai-Nan An, Rochester, MN US

Patent application numberDescriptionPublished
20100057209TEMPOROMANDIBULAR JOINT FOSSA-EMINENCE PROSTHESIS - A fossa-eminence prosthesis having a nonanatomic surface that is relatively flatter than the native fossa. The articular eminence of the patient can be surgically reduced before implanting the prosthesis.03-04-2010
20100221347ENHANCING SOLUTE TRANSPORT WITHIN A TISSUE SCAFFOLD - This document provides materials and methods related to tissue scaffolds for use in replacing or augmenting various tissues in the body. For example, flexible tissue scaffolds with controlled pore geometry and methods of enhancing solute transport using rhythmic compression (e.g., 1.0 Hz) of tissue scaffolds are provided09-02-2010
20110319993TENDON OR LIGAMENT TISSUE ENGINEERING - This document relates to methods and materials involved in tendon or ligament tissue engineering. For example, methods and materials for generating a composite of acellular tendon or ligament allograft slices seeded with cells and bundled into a graft for tissue repair are provided.12-29-2011
20120114755METHODS AND MATERIALS FOR TISSUE REPAIR - This document relates to methods and materials for treating tendon injury. Specifically, methods and materials for preventing adhesion formation and promoting tissue healing following tendon injury and surgical repair are provided.05-10-2012

Patent applications by Kai-Nan An, Rochester, MN US

Ke An, Knoxville, TN US

Patent application numberDescriptionPublished
20090269666Lightweight, Durable Lead-Acid Batteries - A lightweight, durable lead-acid battery is disclosed. Alternative electrode materials and configurations are used to reduce weight, to increase material utilization and to extend service life. The electrode can include a current collector having a buffer layer in contact with the current collector and an electrochemically active material in contact with the buffer layer. In one form, the buffer layer includes a carbide, and the current collector includes carbon fibers having the buffer layer. The buffer layer can include a carbide and/or a noble metal selected from of gold, silver, tantalum, platinum, palladium and rhodium. When the electrode is to be used in a lead-acid battery, the electrochemically active material is selected from metallic lead (for a negative electrode) or lead peroxide (for a positive electrode).10-29-2009
20110294008Lightweight, Durable Lead-Acid Batteries - A lightweight, durable lead-acid battery is disclosed. Alternative electrode materials and configurations are used to reduce weight, to increase material utilization and to extend service life. The electrode can include a current collector having a buffer layer in contact with the current collector and an electrochemically active material in contact with the buffer layer. In one form, the buffer layer includes a carbide, and the current collector includes carbon fibers having the buffer layer. The buffer layer can include a carbide and/or a noble metal selected from of gold, silver, tantalum, platinum, palladium and rhodium. When the electrode is to be used in a lead-acid battery, the electrochemically active material is selected from metallic lead (for a negative electrode) or lead peroxide (for a positive electrode).12-01-2011

Kwang Hyup An, Ann Arbor, MI US

Patent application numberDescriptionPublished
20090134025Scanning device with a probe having an organic material - A probe for a scanning device having an anode, a cathode, and an organic material. The organic material is positioned between the anode and the cathode. The organic material is operable for at least one of emitting and detecting light by an electrical bias applied between the anode and the cathode.05-28-2009
20110291079SURFACE PLASMON-MEDIATED ENERGY TRANSFER OF ELECTRICALLY-PUMPED EXCITONS - An electrically pumped light emitting device emits a light when powered by a power source. The light emitting device includes a first electrode, a second electrode including an outer surface, and at least one active organic semiconductor disposed between the first and second electrodes. The device also includes a dye adjacent the outer surface of the second electrode such that the second electrode is disposed between the dye and the active organic semiconductor. A voltage applied by the power source across the first and second electrodes causes energy to couple from decaying dipoles into surface plasmon polariton modes, which then evanescently couple to the dye to cause the light to be emitted.12-01-2011

Lin An, Portland, OR US

Patent application numberDescriptionPublished
20120063665METHOD AND APPARATUS FOR QUANTITATIVE IMAGING OF BLOOD PERFUSION IN LIVING TISSUE - Embodiments provide methods and systems for imaging, and, more specifically, to a method and apparatus for quantitative imaging of blood perfusion in living tissue. Some embodiments are directed to methods of obtaining quantitative imaging of blood perfusion in living tissues using Doppler optical micro-angiography (DOMAG).03-15-2012

Linan An, Oviedo, FL US

Patent application numberDescriptionPublished
20090209405Method for Synthesizing Bulk Ceramics and Structures from Polymeric Ceramic Precursors - A method and product made by using a polymeric ceramic precursor to synthesize dense, crack-free bulk ceramics in a technique using a sacrificial mold provides a ceramic structure for many technical, medical and industrial applications. The novel process uses an open cell material as a sacrificial mold to shape a ceramic precursor during curing. The cured ceramic green body can be machined and shaped to form the desired ceramic structure prior to final pyrolysis. The open cell material forms gas release paths to release large amount of gases generated during the pyrolysis of the cured ceramic precursor. After pyrolysis, an intact, dense, crack-free ceramic structure with high purity, strength and durability is obtained. Uses of the present invention include, but are not limited to, bulk ceramic parts, ceramic crucibles, a replacement material in some applications involving glass, silicon carbides, silicon nitrides, hafnium carbide and the like.08-20-2009
20100321191CERAMIC SENSORS FOR WIRELESS HIGH-TEMPERATURE SENSING - A RF resonator for sensing a physical or an environmental parameter includes a substrate having a substrate surface. A polymer-derived ceramic (PDC) element is positioned on or within the substrate surface. The RF resonator has a resonant frequency that changes as a function of the physical or environmental parameter. A system for wirelessly sensing at least one physical or environmental parameter includes at least one RF resonator and a wireless RF reader located remotely from the RF resonator for transmitting a wide-band RF interrogation signal that excites the RF resonator. The wireless RF reader detects a sensing signal retransmitted by the RF resonator and includes a processor for determining the physical or environmental parameter at the location of the RF resonator from the sensing signal.12-23-2010

Ling-Ling An, Boyds, MD US

Patent application numberDescriptionPublished
20080311122Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof - Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn s disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, lupus, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.12-18-2008
20090169546HIGH AFFINITY ANTIBODIES AGAINST HMGB1 AND METHODS OF USE THEREOF - Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn s disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.07-02-2009
20100061987High Affinity Antibodies Against HMGB1 and Methods Of Use Thereof - Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn's disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.03-11-2010
20110123528HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF - The invention relates to humanized anti-human Factor D monoclonal antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.05-26-2011
20110165622HUMANIZED ANTI-FACTOR D ANTIBODIES AND USES THEREOF - The invention relates to humanized anti-human Factor D monoclonal antibodies, their nucleic acid and amino acid sequences, the cells and vectors that harbor these antibodies and their use in the preparation of compositions and medicaments for treatment of diseases and disorders associated with excessive or uncontrolled complement activation. These antibodies are useful for diagnostics, prophylaxis and treatment of disease.07-07-2011
20110287023High Affinity Antibodies Against HMGB1 and Methods of Use Thereof - Compositions and methods are disclosed for inhibiting the release of a proinflammatory cytokine from a vertebrate cell, and for inhibiting an inflammatory cytokine cascade in a patient. The compositions comprise, for example, high affinity antibodies that specifically bind HMG1 and antigenic fragments thereof. The high affinity antibodies of the present invention and pharmaceutical compositions comprising the same are useful for many purposes, for example, as therapeutics against a wide range of inflammatory diseases and disorders such as sepsis, rheumatoid arthritis, peritonitis, Crohn's disease, reperfusion injury, septicemia, endotoxic shock, cystic fibrosis, endocarditis, psoriasis, psoriatic arthritis, arthritis, anaphylactic shock, organ ischemia, reperfusion injury, and allograft rejection. In addition, the high affinity antibodies of the present inventions are useful as diagnostic antibodies.11-24-2011

Patent applications by Ling-Ling An, Boyds, MD US

Moens An, Baltimore, MD US

Patent application numberDescriptionPublished
20100004248Use of a Nitric Oxide Synthase Modulator for the Treatment of Cardiac Indications - The invention features compositions and methods for modulating NOS that are useful for the prevention and treatment of cardiac diseases and disorders, including cardiac hypertrophy and cardiac dilation. In particular, the invention provides compositions comprising tetrahydrobiopterin (BH4), alone or in combination with one or more additional compounds.01-07-2010

Na An, Salt Lake City, UT US

Patent application numberDescriptionPublished
20120091005DETECTION OF NUCLEIC ACID LESIONS AND ADDUCTS USING NANOPORES - Methods, systems, and compounds for detecting modified nucleic acid bases are disclosed and described. The methods provide for detecting a nucleic acid lesion and can include directing a nucleic acid adduct into a channel, wherein the nucleic acid adduct includes a nucleic acid having a lesion and a current modulating compound coupled to the nucleic acid at the lesion (04-19-2012

Pao Yu An, Morris Plains, NJ US

Patent application numberDescriptionPublished
20080295431Reversible planking system and method for making thereof - A reversible composite simulated beadboard planking and a method for making the same are provided. The planking may include a first finished side, a second finished side opposite the first finished side, a first pattern including integrally-formed uneven profile simulating a beadboard of a first plank width on the first finished side, a second pattern including integrally-formed uneven profile simulating a beadboard of a second plank width different than the first plank width on the second finished side, a base pigment distributed substantially uniformly throughout the planking, and a tongue structure on a first edge substantially adjacent to the first finished side and the second finished side, and a groove structure on a second edge opposite the first edge, the groove structure configured to receive the tongue structure from another similarly configured composite planking.12-04-2008

Ping An, Katy, TX US

Patent application numberDescriptionPublished
20080232193Methods for Noise Removal and/or Attenuation from Seismic Data by Wavelet Selection - Seismic data traces contain noises that may exist in the form of wavelets and be represented by wavelets. A method is established for removing or attenuating the noises in the seismic data traces by removing the wavelets or representing wavelets of noises in the seismic data traces. The method involves three steps. (1) Decomposition of each seismic data trace into a set of time dependent wavelets of different shapes. The obtained wavelets can be named with their dominant frequency or other characteristics of the wavelets. (2) Proper selection of the wavelets to form a new set of wavelets that contains mostly signal wavelets and rejects the wavelets of noises and representing wavelets of noises as mush as possible. This step can also be described as to remove the wavelets of noises and representing wavelets of noises from the obtained set of wavelets from step one and form a new set of wavelets. (3) Composition or reconstruction of a new seismic data trace with the new selected set of wavelets. The new reconstructed seismic data trace is the resulting seismic data trace. It normally have much higher signal to noise ratio than the original seismic data trace.09-25-2008
20080285383System and method for processing seismic data for interpretation - A method is provided for processing seismic data for interpretation. The method includes recording an original seismic data trace, decomposing the original seismic data trace into a set of predefined wavelets, and reconstructing a seismic data trace from, at least a subset of, the set of wavelets.11-20-2008

Qi An, New Brighton, MN US

Seong Soo Alexander An, Ithaca, NY US

Patent application numberDescriptionPublished
20100009388DIFFERENTIAL DETECTION OF MULTIMERIC AND MONOMERIC FORMS OF MULTIMER-FORMING POLYPEPTIDES - A method for differentially detecting a multimeric form from a monomeric form of a multimer-forming polypeptide in a biosample includes (a) contacting the biosample to a capturing antibody recognizing an epitope on the multimer-forming polypeptide to capture the monomeric form, multimeric form or monomeric and multimeric forms; (b) contacting the monomeric form, multimeric form or monomeric and multimeric forms captured to a detecting antibody recognizing an epitope identical to or overlapped with the epitope of step (a); and (c) detecting the formation of a multimeric form-detection antibody complex.01-14-2010
20100021943Methods for differentially detecting a multimeric form from a monomeric form of a multimer-forming polypeptide through three-dimensional interactions - The present invention relates to a method for differentially detecting a multimeric form from a monomeric form of a multimer-forming polypeptide in a biosample, which comprises the steps of: (a) preparing a carrier-capturing antibody conjugate by binding a capturing antibody to the surface of a solid phase carrier in a three dimensional manner, wherein the capturing antibody is capable of recognizing an epitope on the multimer-forming polypeptide; (b) preparing a detection antibody, wherein an epitope recognized by the detection antibody is present at a position in the multimer-forming polypeptide to cause a steric hindrance by the capturing antibody bound to its epitope to prevent the binding of the detection antibody to the multimer-forming polypeptide; (c) contacting simultaneously the carrier-capturing antibody conjugate and the detection antibody to the biosample; and (d) detecting the formation of a carrier-capturing antibody-multimeric form-detection antibody complex.01-28-2010

Stephen H. An, Boston, MA US

Patent application numberDescriptionPublished
20110047471Apparatus and Methods for Associating a User's Activity in Relation to a Physical Location with a Virtual Community - A system permits a user's activity in relation to a physical location to be associated with a virtual community web site and, therefore, with a virtual community created by the web site. Users indicate their presence at, or association with, a physical location by sending messages from their personal communication devices, such as mobile telephones or Internet-connected computers. Users may participate in activities at the locations by sending such messages, accessing location proxy web sites or via virtual communities. An exemplary activity includes a network-connected jukebox. Users may obtain information about music being played on the jukebox. In addition, the jukebox may display information about music being played on other jukeboxes, possibly in other locations.02-24-2011

Tonya An, Grand Rapids, MI US

Patent application numberDescriptionPublished
20110164128IMAGE CAPTURE AND EARPIECE SIZING SYSTEM AND METHOD - A method and system for sizing an earpiece include situating a calibration device proximate a user's ear. The user holds an image capture device so as to aim the image capture device at the user's ear. The user then touches and holds a random area of the touch screen display and releases the touch screen display to activate the image capture device and capture an image of the user's ear and the calibration device. The captured image is then analyzed and an earpiece size is determined based on the analysis of the image.07-07-2011

Wei An, Auburndale, MA US

Patent application numberDescriptionPublished
20110103450OFDM CHANNEL ESTIMATION SYSTEM AND METHOD COMPONENTS - Channel estimation for high mobility OFDM channels is achieved by identifying a set of channel path delays from an OFDM symbol stream including carrier data, inter-channel interference noise and channel noise; determining the average channel impulse response for the identified set of channel path delays in each symbol; generating a path delay curvature for each channel path delay in each symbol based on stored average channel impulse responses for the identified channel path delays; estimating the carrier data in the symbols in the OFDM symbol stream in the presence of inter-channel interference noise and channel noise from the OFDM symbol steam and the average impulse responses for the identified channel path delays; reconstructing the inter-channel interference noise in response to the path delay curvature, the identified set of channel path delays and estimated carrier data to produce a symbol stream of carrier data and channel noise with suppressed inter-channel interference noise.05-05-2011
20110103453OFDMCHANNEL ESTIMATION SYSTEM AND METHOD COMPONENTS - Channel estimation for high mobility OFDM channels is achieved by identifying a set of channel path delays from an OFDM symbol stream including carrier data, inter-channel interference noise and channel noise; determining the average channel impulse response for the identified set of channel path delays in each symbol; generating a path delay curvature for each channel path delay in each symbol based on stored average channel impulse responses for the identified channel path delays; estimating the carrier data in the symbols in the OFDM symbol stream in the presence of inter-channel interference noise and channel noise from the OFDM symbol steam and the average impulse responses for the identified channel path delays; reconstructing the inter-channel interference noise in response to the path delay curvature, the identified set of channel path delays and estimated carrier data to produce a symbol stream of carrier data and channel noise with suppressed inter-channel interference noise.05-05-2011
20110182340OFDM CHANNEL ESTIMATION SYSTEM AND METHOD COMPONENTS - Channel estimation for high mobility OFDM channels is achieved by identifying a set of channel path delays from an OFDM symbol stream including carrier data, inter-channel interference noise and channel noise; determining the average channel impulse response for the identified set of channel path delays in each symbol; generating a path delay curvature for each channel path delay in each symbol based on stored average channel impulse responses for the identified channel path delays; estimating the carrier data in the symbols in the OFDM symbol stream in the presence of inter-channel interference noise and channel noise from the OFDM symbol steam and the average impulse responses for the identified channel path delays; reconstructing the inter-channel interference noise in response to the path delay curvature, the identified set of channel path delays and estimated carrier data to produce a symbol stream of carrier data and channel noise with suppressed inter-channel interference noise.07-28-2011
20110182374OFDM CHANNEL ESTIMATION SYSTEM AND METHOD COMPONENTS - Channel estimation for high mobility OFDM channels is achieved by identifying a set of channel path delays from an OFDM symbol stream including carrier data, inter-channel interference noise and channel noise; determining the average channel impulse response for the identified set of channel path delays in each symbol; generating a path delay curvature for each channel path delay in each symbol based on stored average channel impulse responses for the identified channel path delays; estimating the carrier data in the symbols in the OFDM symbol stream in the presence of inter-channel interference noise and channel noise from the OFDM symbol steam and the average impulse responses for the identified channel path delays; reconstructing the inter-channel interference noise in response to the path delay curvature, the identified set of channel path delays and estimated carrier data to produce a symbol stream of carrier data and channel noise with suppressed inter-channel interference noise.07-28-2011

Wei An, Waltham, MA US

Patent application numberDescriptionPublished
20100194635METHOD AND APPARATUS FOR SOFTWARE GPS RECEIVER - A receiver architecture for processing spread spectrum signals. The receiver has an RF front end to receive and down convert a broadcast signal to an intermediate frequency carrier. The IF signal is digitized and provided to a processor (which may be a software-driven DSP, an ASIC or other embodiment) for processing. A given IF carrier is removed and the signal is low pass filtered. The signal is provided to a number of channels, each, for example, correspond to a unique transmitter. On each channel the sample rate is reduced to a predetermined fixed rate with timing mismatch compensated. The Doppler frequency shift, as estimated for the channel, is removed succeedingly. A locally generated copy of the spreading code used by the transmitter is applied to the carrier and Doppler removed signal at the predetermined fixed sample rate. The de-spread signal is used to provide estimates of the Doppler shift and for subsequent sample selection. Pseudo-range and delta pseudo-range estimates from each channel are used to estimate, for example, the receiver's position.08-05-2010

Patent applications by Wei An, Waltham, MA US

Wei An, Newton, MA US

Patent application numberDescriptionPublished
20110026577Equalization for OFDM Communication - The problem of inefficient channel impulse-response processing is addressed by processing different parts of a channel impulse response to accurately locate channel taps, and to generate more than one set of equalization coefficients. This allows the most-suited equalization coefficient to be selected based on a selection criterion.02-03-2011

William An, Flushing, NY US

Patent application numberDescriptionPublished
20110137219Method and apparatus to grow hair - A method for growing hair includes the steps of detecting a trigger point in proximity to the area for hair growth, reducing the trigger point in proximity to the area for hair growth, and massaging the area for hair growth. The step of massaging may include manual massaging and may include electronically massaging.06-09-2011

Xiuli An, Bayside, NY US

Patent application numberDescriptionPublished
20100323393Ordered Assembly of Membrane Proteins During Differentiation of Erythroblasts - Disclosed herein are methods for the isolation, identification, and quantification of red blood cells and red blood cell precursors at different developmental stages. Also disclosed are methods for monitoring ex vivo proliferation and differentiation of red blood cells and red blood cell progenitors.12-23-2010

Yong-Su An US

Patent application numberDescriptionPublished
20110227850TOUCH SENSING TYPE LIQUID CRYSTAL DISPLAY DEVICE AND METHOD OF FABRICATING THE SAME - A touch sensing type liquid crystal display device includes an array substrate includes an array substrate including a first substrate, a common electrode, a pixel electrode, and a touch sensing unit; a color filter substrate including a second substrate and facing the array substrate; an anti-static layer on an outer side of the second substrate and including an inorganic material and conductive particles; and a liquid crystal layer between the first substrate and an inner side of the second substrate.09-22-2011

Yu An, Sammamish, WA US

Patent application numberDescriptionPublished
20100185787DYNAMIC CALL HANDLING FROM MULTIPLE ATTACHED DEVICES - Multiple peripheral devices are used for various modes of communication in a unified communication application. Employing standard or custom protocols, connected peripheral devices can be configured automatically and different modes of communication such as audio, video, data, and text, are routed to available or selected peripheral devices. Incoming communication requests can be extended to multiple peripheral devices synchronously and users enabled to switch between peripheral devices seamlessly during a communication session.07-22-2010

Zesheng An, Smyrna, GA US

Patent application numberDescriptionPublished
20080223444Perylene Charge-Transport Materials, Methods of Fabrication Thereof, and Methods of Use Thereof - Briefly described, embodiments of this disclosure include perylenetetracarboxylic diimide charge-transport materials, methods of forming perylenetetracarboxylic diimide charge-transport materials, and methods of using the perylenetetracarboxylic diimide charge-transport materials.09-18-2008
20090044863CORONENE CHARGE-TRANSPORT MATERIALS, METHODS OF FABRICATION THEREOF, AND METHODS OF USE THEREOF - Briefly described, embodiments of this disclosure include coronene charge-transport materials, methods of forming coronene charge-transport materials, and methods of using the coronene charge-transport materials.02-19-2009

Zhiqiang An, Ambler, PA US

Patent application numberDescriptionPublished
20090285799Antibody Antagonists of Interleukin-13 Receptor Alpha1 - Antibody antagonists of human interleukin-13 receptor alpha 1 are disclosed. The antibody molecules are useful in the inhibition of IL-13Rα1-mediated activities and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with hIL-13Rα1 activity. The present invention also discloses nucleic acid encoding said antibody molecules, vectors, host cells, and compositions comprising the antibody molecules. Methods of using the antibody molecules for inhibiting or antagonizing IL-13Rα1-mediated activities are also disclosed.11-19-2009
20100166772ANTIGEN-BINDING PROTEINS TARGETING S. AUREUS ORF0657n - The present invention features antigen binding proteins that bind to a region found to have an epitope that can be targeted to provide protection against 07-01-2010
20100239597Anti-ADDL monoclonal antibody and use thereof - The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The present antibodies also block binding of ADDLs to neurons, assembly of ADDLs, and tau phosphorylation and are there useful in methods for the preventing and treating diseases associated with soluble oligomers of amyloid β 1-42.09-23-2010
20100272714Anti-ADDL Antibodies and Uses Thereof - The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The present antibodies also block binding of ADDLs to neurons, assembly of ADDLs, and tau phosphorylation and are there useful in methods for the preventing and treating diseases associated with soluble oligomers of amyloid β 1-42.10-28-2010
20100285035High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1 - High affinity antibody antagonists of human interleukin-13 receptor alpha 1 are disclosed. The antibody molecules are effective in the inhibition of IL-13Rα1-mediated activities and, accordingly, present desirable antagonists for the use in the treatment of conditions associated with hIL-13Rα1 activity. The present invention also discloses nucleic acid encoding said antibody molecules, vectors, host cells, and compositions comprising the antibody molecules. Methods of using the antibody molecules for inhibiting or antagonizing IL-13Rα1-mediated activities are also disclosed.11-11-2010
20110052597Anti-IL-13R Alpha1 Antibodies and Their Uses Thereof - Antibody antagonists of human interleukin-13 receptor alpha 1 which bind to hIL-13Rα1 through domain 3 of the extracellular region of the receptor and inhibit IL-13 receptor-mediated signaling by IL-13 are disclosed herein. These antibodies have uses inter alia in the treatment or prevention of IL-13-related disorders and diseases. The present invention also discloses nucleic acid encoding said antibody molecules, vectors, host cells, and compositions comprising the antibody molecules. Methods of using the antibody molecules for inhibiting or antagonizing hIL-13Rα1-mediated activities are also disclosed.03-03-2011
20110159013Anti-ADDL Antibodies and Uses Thereof - The present invention relates to antibodies that differentially recognize multi-dimensional conformations of Aβ-derived diffusible ligands, also known as ADDLs. The antibodies of the invention can distinguish between Alzheimer's Disease and control human brain extracts and are useful in methods of detecting ADDLs and diagnosing Alzheimer's Disease. The present antibodies also block binding of ADDLs to neurons, assembly of ADDLS, and tau phosphorylation and are there useful in methods for the preventing and treating diseases associated with soluble oligomers of amyloid β 1-42.06-30-2011

Patent applications by Zhiqiang An, Ambler, PA US